title: Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells.
abstract: Chemokines are cytokines with chemotactic properties on inflammatory cells and other cell types. Chemokine (C-C motif) ligand 2 (CCL2), which is also called monocyte chemotactic protein 1 (MCP-1), is a potent chemotactic molecule that attracts lymphocytes, monocytes, mast cells, and memory T cells, but not neutrophils. CCL2/MCP-1 represents a link between the activation of monocytes, lymphocytes, basophils, mast cells, and eosinophils in inflammatory disorders, such as the late-phase allergic reaction. This C-C chemokine also plays a role in regulating Th-cell cytokine production and leukocyte trafficking. Laboratory of allergic diseases (LAD) cells is the first reported human mast cell line that closely resembles a primary culture of CD34+-derived human mast cells. These cells were cultured in vitro and treated with different concentrations of substance P (SP) for the production of CCL2/MCP-1. We used calcium ionophore as a positive control for stimulating transcription and translation of CCL2/MCP-1. The stimulation of SP on CCL2/MCP-1 was statistically significant (P < 0.05) compared with the control (untreated cells). In this study, we determined the expression and secretion of CCL2/MCP-1 from SP-activated LAD2 human mast cells in vitro. The levels of CCL2/MCP-1 from SP-activated LAD2 human mast cells were higher at 10 microM and at 18 h incubation compared with controls. This effect was also revealed on CCL2/MCP-1 messenger RNA (mRNA) expression, as determined by reverse transcriptase polymerase chain reaction (RT-PCR) analysis. Our data suggest that SP is an important neurotransmitter that can stimulate the chemokine CCL2, which plays a fundamental role in inflammation by recruiting inflammatory cells to specific cites.
authors.affiliation: Immunology Division, Medical School, University of Chieti-Pescara, Chieti, Italy.
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Castellani
authors.forename: Jacopo
authors.initials: J
authors.lastname: Vecchiet
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Salini
authors.forename: Pio
authors.initials: P
authors.lastname: Conti
authors.forename: Theoharis C
authors.initials: TC
authors.lastname: Theoharides
authors.forename: Auro
authors.initials: A
authors.lastname: Caraffa
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Antinolfi
authors.forename: Stefano
authors.initials: S
authors.lastname: Teté
authors.forename: Cristian
authors.initials: C
authors.lastname: Ciampoli
authors.forename: Chiara
authors.initials: C
authors.lastname: Cuccurullo
authors.forename: Giuliano
authors.initials: G
authors.lastname: Cerulli
authors.forename: Mario
authors.initials: M
authors.lastname: Felaco
authors.forename: Paolo
authors.initials: P
authors.lastname: Boscolo
mesh_terms: D002460:Cell Line; D018932:Chemokine CCL2 / Q000235:genetics*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D066298:In Vitro Techniques; D008407:Mast Cells / Q000187:drug effects* / Q000502:physiology*; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013373:Substance P / Q000494:pharmacology*
chemical_list: C111835:CCL2 protein, human; D018932:Chemokine CCL2; D012333:RNA, Messenger; D013373:Substance P